Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Improving Pelvic Cancer Patient Chemoradiotherapy Outcomes With FLT PET Imaging

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01717391
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:21.623602+00:00
Published At
2017-09-05T00:00:00+00:00
Record Updated At
2019-03-26
Results Posted At
2017-09-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Uterine Cervical Neoplasms", "Endometrial Neoplasms", "Anus Neoplasms", "Rectal Neoplasms", "Prostatic Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-03-26"
protocolSection.identificationModule.nctId
"NCT01717391"
protocolSection.identificationModule.officialTitle
"Improving Pelvic Cancer Patient Chemoradiotherapy Outcomes With FLT PET Imaging"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-09-05"

Study condition terms

  • Uterine Cervical Neoplasms (protocolSection.conditionsModule.conditions)
  • Endometrial Neoplasms (protocolSection.conditionsModule.conditions)
  • Anus Neoplasms (protocolSection.conditionsModule.conditions)
  • Rectal Neoplasms (protocolSection.conditionsModule.conditions)
  • Prostatic Neoplasms (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.